Immune checkpoint inhibitors in challenging populations
Sign Up to like & getrecommendations! Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30642
Abstract: Immune checkpoint inhibitors, including those targeting the programmed cell death 1/programmed cell death ligand 1 and cytotoxic T lymphocyte antigen 4 pathways, are revolutionizing cancer therapeutics. Both activity and toxicities largely stem from unleashing tumor‐… read more here.
Keywords: challenging populations; immune checkpoint; checkpoint inhibitors; checkpoint ... See more keywords